Dr. Shawn Baca, MD
What this data tells you about Dr. Baca
Dr. Shawn Baca is a rheumatology in Delray Beach, FL, with 19 years in practice. Based on federal Medicare data, Dr. Baca performed 183,033 Medicare services across 11,997 unique beneficiaries.
Between the years covered by Open Payments, Dr. Baca received a total of $22,281 from 43 pharmaceutical and/or device companies across 1071 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in rheumatology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Baca is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
Medicare Practice Summary
Medicare Utilization ↗Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) | 48,800 | $4 | $10 |
| Tocilizumab injection (Actemra) | 40,400 | $5 | $7 |
| Romosozumab injection (Evenity) for osteoporosis | 36,960 | $8 | $15 |
| Denosumab injection (Prolia/Xgeva) | 26,700 | $18 | $25 |
| Abatacept infusion (Orencia) | 7,700 | $34 | $60 |
| Golimumab infusion (Simponi Aria) | 4,100 | $10 | $32 |
| Office visit, established patient (30-39 min) | 1,838 | $100 | $271 |
| Blood draw (venipuncture) | 1,643 | $8 | $10 |
| Administration of non-hormonal anti-neoplastic chemotherapy under skin or into muscle | 1,162 | $59 | $159 |
| Calcium level, total | 950 | $5 | $11 |
| Vitamin D level test | 929 | $29 | $73 |
| Office visit, established patient (20-29 min) | 924 | $67 | $191 |
| Blood creatinine level | 874 | $5 | $10 |
| Urea nitrogen level to assess kidney function, quantitative | 826 | $4 | $10 |
| Blood potassium level | 794 | $5 | $10 |
| Blood glucose (sugar) level | 792 | $4 | $10 |
| Blood sodium level | 789 | $5 | $10 |
| Red blood cell sedimentation rate, to detect inflammation, non-automated | 682 | $4 | $9 |
| C-reactive protein test (inflammation marker) | 651 | $5 | $13 |
| Complete blood count (CBC) with differential | 633 | $8 | $19 |
| Liver function blood test panel | 605 | $8 | $20 |
| Injection, methylprednisolone acetate, 40 mg | 367 | $6 | $12 |
| Phosphate level test | 349 | $5 | $10 |
| Phosphatase (enzyme) measurement, alkaline, isoenzymes | 347 | $14 | $30 |
| Bone density scan (DEXA) | 313 | $39 | $79 |
| Measurement of antibody for assessment of autoimmune disorder, any method | 230 | $18 | $89 |
| Joint injection, major joint | 206 | $59 | $149 |
| Administration of chemotherapy into vein, 1 hour or less | 203 | $100 | $205 |
| Parathyroid hormone level test | 187 | $40 | $102 |
| New patient office visit (45-59 min) | 162 | $127 | $354 |
| Screening test for autoimmune disorder | 144 | $12 | $30 |
| Measurement of complement (immune system proteins), antigen, | 134 | $12 | $59 |
| Thyroid stimulating hormone (TSH) test | 132 | $16 | $42 |
| Rheumatoid factor analysis | 119 | $6 | $14 |
| Injection of trigger points, 1-2 muscles | 107 | $39 | $116 |
| Creatine kinase (cardiac enzyme) level, total | 101 | $6 | $16 |
| Injection of trigger points, 3 or more muscles | 99 | $49 | $132 |
| Injection, zoledronic acid, 1 mg | 95 | $6 | $45 |
| Analysis of substance using immunoassay technique, multiple step method | 91 | $11 | $28 |
| Free thyroxine (T4) test | 89 | $9 | $22 |
| Uric acid level test | 63 | $4 | $11 |
| Screening test for antibody to noninfectious agent | 63 | $12 | $29 |
| New patient office visit (30-44 min) | 63 | $87 | $237 |
| Measurement of dna antibody, native or double stranded | 61 | $13 | $34 |
| Urinalysis, manual | 49 | $3 | $7 |
| Hyaluronan or derivative, euflexxa, for intra-articular injection, per dose | 46 | $99 | $300 |
| Injection of additional new drug or substance into vein | 44 | $13 | $65 |
| Injection, hydrocortisone sodium succinate, up to 100 mg | 44 | $14 | $20 |
| X-ray of knee, 1-2 views | 38 | $27 | $71 |
| Cortisol (hormone) measurement, total | 34 | $16 | $40 |
| Steroid injection (triamcinolone) | 33 | $1 | $10 |
| Shoulder X-ray, 2+ views | 32 | $27 | $71 |
| Aspiration and/or injection of fluid from small joint | 26 | $40 | $114 |
| Office visit, established patient, complex (40-54 min) | 22 | $147 | $379 |
| Injection, methylprednisolone acetate, 80 mg | 22 | $9 | $22 |
| New patient office visit, complex (60-74 min) | 21 | $165 | $468 |
| Iron level test | 19 | $6 | $16 |
| Flu vaccine, high-dose | 19 | $72 | $89 |
| Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less | 19 | $49 | $105 |
| Flu vaccine administration | 19 | $32 | $59 |
| Injection into tendon or ligament | 16 | $44 | $120 |
| X-ray of lower and sacral spine, 2-3 views | 15 | $33 | $79 |
| Measurement of antibody for assessment of autoimmune disorder, titer | 14 | $11 | $30 |
| Aspiration and/or injection of fluid from medium joint | 12 | $43 | $116 |
| X-ray of middle spine, 2 views | 12 | $27 | $68 |
Industry Payment Transparency
Open Payments through 2024 ↗Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
Payments by company (2024)
Associated products mentioned in payments ›
Most payments (83%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Geographic Context
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Baca is a mixed practice specialist, with above-average Medicare volume (top 10% in FL), and low-engagement industry engagement, with 19 years of practice experience.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Baca experienced with certolizumab injection (cimzia)?
Does Dr. Baca receive payments from pharmaceutical companies?
How do Dr. Baca's costs compare to other rheumatologys in Delray Beach?
What does Data Coverage mean?
Is this data up to date?
Explore related providers
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology